BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26321470)

  • 1. Five year trends in dyslipidaemia prevalence and management in Switzerland: the CoLaus study.
    Antiochos P; Marques-Vidal P; Waeber G; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1007-15. PubMed ID: 26321470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
    Gupta R; Guptha S; Gupta VP; Agrawal A; Gaur K; Deedwania PC
    Eur J Prev Cardiol; 2012 Dec; 19(6):1258-71. PubMed ID: 21947630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.
    Firmann M; Marques-Vidal P; Paccaud F; Mooser V; Rodondi N; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):682-7. PubMed ID: 20700055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of optimal lipid value achievement between 2005 and 2009 in patients with mixed dyslipidaemia on cardiovascular event rates.
    Cziraky MJ; Tan H; Bullano MF; Yu J; Schiebinger R; Willey VJ
    Int J Clin Pract; 2011 Apr; 65(4):425-35. PubMed ID: 21401832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The magnitude of atherogenic dyslipidaemia among geriatric Nigerians with systemic hypertension in a rural hospital in Eastern Nigeria.
    Iloh GU; Ofoedu JN; Amadi AN; Obikwu CE
    Niger J Med; 2012; 21(3):320-5. PubMed ID: 23304929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study.
    Peer N; Steyn K; Lombard C; Gaziano T; Levitt N
    Eur J Prev Cardiol; 2014 Dec; 21(12):1549-56. PubMed ID: 23881149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
    Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
    Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.
    Mohamed-Yassin MS; Baharudin N; Daher AM; Abu Bakar N; Ramli AS; Abdul-Razak S; Mohamed Noor Khan NA; Mohamad M; Yusoff K
    BMC Cardiovasc Disord; 2021 Mar; 21(1):149. PubMed ID: 33757445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
    Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
    Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital.
    Wang SH; Wang L; Zhou Y; Guo YJ; Yuan Y; Li FF; Huang Y; Xia WQ
    Diab Vasc Dis Res; 2013 Mar; 10(2):169-78. PubMed ID: 22906862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: a 15-year follow-up of the Chinese Multi-provincial Cohort Study.
    Liu J; Wang W; Wang M; Sun J; Liu J; Li Y; Qi Y; Wu Z; Zhao D
    Diabetes Res Clin Pract; 2012 May; 96(2):217-24. PubMed ID: 22244364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.